<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000632148"><TermName>daunomycin</TermName><TermPronunciation>(DAW-noh-MY-sin)</TermPronunciation><TermDefinition><DefinitionText>The active ingredient in a drug used to treat acute leukemias and some other types of cancer. It blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called daunorubicin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000723109" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;daunomycin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000723108" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;daunomicina&quot;" language="es" id="_4"/><SpanishTermName>daunomicina</SpanishTermName><SpanishTermDefinition><DefinitionText>Ingrediente activo de un medicamento que se usa para tratar leucemias agudas y otros tipos de cáncer. Bloquea cierta enzima que se necesita para la multiplicación celular y para reparar el ADN, y puede eliminar células cancerosas. Es un tipo de antibiótico de antraciclina y un tipo de inhibidor de la topoisomerasa. También se llama daunorrubicina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-01-06</DateFirstPublished></GlossaryTerm>
